Radiation Oncology Journal10.3857/roj.2017.000942017352153-162Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective studySeung Yeun Chung, Jong Hee Chang, Hye Ryun Kim, Byoung Chul Cho, Chang Geol Lee, Chang-Ok Suh,,
Radiotherapy and Oncology10.1016/s0167-8140(01)80346-7200158S60205 oral Radiation therapy or brain metastases from lung cancer. A retrospective study on 299 patients,
Lung Cancer10.1016/s0169-5002(11)70165-9201171S1728IN STEREOTACTIC BODY RADIOTHERAPY FOR PULMONARY OLIGOMETASTASESF.J. Lagerwaard,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2016.06.8232016962E92Optimal Dose and Volume for Postoperative Radiation Therapy in Patients With 1 to 4 Brain Metastases From Lung CancerS.Y. Chung, J.H. Chang, C.G. Lee, C.O. Suh,
Lung Cancer10.1016/s0169-5002(96)80078-x1996153398A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial,
Radiotherapy and Oncology10.1016/s0167-8140(01)80881-1200161S82238 poster Pattern of relapse after postoperative three-dimensional conformal radiotherapy (3D-CRT) for non-small-cell lung cancer (NSCLC) accordency dose volume histogram (DVH) indepartment of radiotherapy, Centre Leon Berard, Lyon, France,
Lung Cancer10.1016/s0169-5002(03)92141-6200341S134P-172 Postoperative radiotherapy for nones mall cell lung cancer, a retrospective reviewJian-Sheng Jan, Jin-Ching Lin, Yih-Chyang Wen, Lilly Wang,
Radiotherapy and Oncology10.1016/s0167-8140(02)83496-x200265S1772 Lung complications in radiation treatment of malignant thymoma: A retrospective analysis of dose-volume dependence,
Radiotherapy and Oncology10.1016/s0167-8140(04)82393-4200473S235525 poster Optimal dose fractionation of lung cancer using biologically optimized IMRT,
Lung Cancer10.1016/s0169-5002(18)30164-82018115S58-S59Stereotactic radiosurgery for brain oligometastases from non-small cell lung cancerM. O’Cathail, J.W. Ho, K. Foweraker, R. Clements, A. Bangiri, L. Aznar-Garcia,